id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-N-0026-0033,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; AQNEURSA (Levacetylleucine),Notice,Announcement,2024-10-15T04:00:00Z,2024,10,,,2024-10-15T18:42:22Z,2024-23712,0,0,09000064867ce892
FDA-2020-N-0026-0032,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; MIPLYFFA (Arimoclomol),Notice,Announcement,2024-10-15T04:00:00Z,2024,10,,,2024-10-15T18:42:10Z,2024-23646,0,0,09000064867ce712
FDA-2020-N-0026-0031,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; LIVMARLI (maralixibat),Notice,Announcement,2024-08-28T04:00:00Z,2024,8,2024-08-28T04:00:00Z,,2024-08-28T13:55:40Z,2024-19334,0,0,09000064866b0229
FDA-2020-N-0026-0030,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; XOLREMDI (mavorixafor),Notice,Announcement,2024-05-16T04:00:00Z,2024,5,,,2024-05-16T12:55:40Z,2024-10715,0,0,0900006486568fbb
FDA-2020-N-0026-0029,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; OJEMDA (tovorafenib),Notice,Announcement,2024-05-15T04:00:00Z,2024,5,2024-05-15T04:00:00Z,,2024-05-15T13:21:52Z,2024-10583,0,0,0900006486566994
FDA-2020-N-0026-0028,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; DUVYZAT (givinostat),Notice,Announcement,2024-04-11T04:00:00Z,2024,4,2024-04-11T04:00:00Z,,2024-04-11T14:00:15Z,2024-07657,0,0,09000064864cd930
FDA-2020-N-0026-0026,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2024-01-11T05:00:00Z,2024,1,2024-01-11T05:00:00Z,,2024-01-11T14:57:56Z,2024-00400,0,0,09000064863921da
FDA-2020-N-0026-0027,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2024-01-11T05:00:00Z,2024,1,2024-01-11T05:00:00Z,,2024-01-11T17:10:21Z,2024-00401,0,0,090000648639237b
FDA-2020-N-0026-0025,FDA,FDA-2020-N-0026,Issuance of Priority Review Voucher; Rare Pediatric Disease Product,Notice,Announcement,2024-01-09T05:00:00Z,2024,1,2024-01-09T05:00:00Z,,2024-01-09T14:08:36Z,2024-00263,0,0,09000064863887b3